131 related articles for article (PubMed ID: 19056949)
1. Genetics. Hopping to a better protein.
Pennisi E
Science; 2008 Dec; 322(5907):1454-5. PubMed ID: 19056949
[No Abstract] [Full Text] [Related]
2. Gene therapy: the 'pro-sense' approach to Duchenne muscular dystrophy.
van Deutekom JC
Eur J Hum Genet; 2005 May; 13(5):518-9. PubMed ID: 15714219
[No Abstract] [Full Text] [Related]
3. Myodys, a full-length dystrophin plasmid vector for Duchenne and Becker muscular dystrophy gene therapy.
Duan D
Curr Opin Mol Ther; 2008 Feb; 10(1):86-94. PubMed ID: 18228186
[TBL] [Abstract][Full Text] [Related]
4. Induced dystrophin exon skipping in human muscle explants.
McClorey G; Fall AM; Moulton HM; Iversen PL; Rasko JE; Ryan M; Fletcher S; Wilton SD
Neuromuscul Disord; 2006 Oct; 16(9-10):583-90. PubMed ID: 16919955
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy progress and prospects: Duchenne muscular dystrophy.
Foster K; Foster H; Dickson JG
Gene Ther; 2006 Dec; 13(24):1677-85. PubMed ID: 17066097
[TBL] [Abstract][Full Text] [Related]
6. Transduction of myogenic cells by retargeted dual high-capacity hybrid viral vectors: robust dystrophin synthesis in duchenne muscular dystrophy muscle cells.
Gonçalves MA; Holkers M; Cudré-Mauroux C; van Nierop GP; Knaän-Shanzer S; van der Velde I; Valerio D; de Vries AA
Mol Ther; 2006 May; 13(5):976-86. PubMed ID: 16443396
[TBL] [Abstract][Full Text] [Related]
7. Modification of pre-mRNA processing: application to dystrophin expression.
Wilton SD; Fletcher S
Curr Opin Mol Ther; 2006 Apr; 8(2):130-5. PubMed ID: 16610765
[TBL] [Abstract][Full Text] [Related]
8. Exon skipping with morpholino oligomers: new treatment option for cardiomyopathy in Duchenne muscular dystrophy?
Bauer R; Katus HA; Müller OJ
Cardiovasc Res; 2010 Feb; 85(3):409-10. PubMed ID: 20008475
[No Abstract] [Full Text] [Related]
9. [Molecular therapy for duchenne muscular dystrophy].
Takeshima Y
Nihon Rinsho; 2005 Dec; 63 Suppl 12():626-31. PubMed ID: 16416864
[No Abstract] [Full Text] [Related]
10. Efficient and fast functional screening of microdystrophin constructs in vivo and in vitro for therapy of duchenne muscular dystrophy.
Jørgensen LH; Larochelle N; Orlopp K; Dunant P; Dudley RW; Stucka R; Thirion C; Walter MC; Laval SH; Lochmüller H
Hum Gene Ther; 2009 Jun; 20(6):641-50. PubMed ID: 19239382
[TBL] [Abstract][Full Text] [Related]
11. Effective rescue of dystrophin improves cardiac function in dystrophin-deficient mice by a modified morpholino oligomer.
Wu B; Moulton HM; Iversen PL; Jiang J; Li J; Li J; Spurney CF; Sali A; Guerron AD; Nagaraju K; Doran T; Lu P; Xiao X; Lu QL
Proc Natl Acad Sci U S A; 2008 Sep; 105(39):14814-9. PubMed ID: 18806224
[TBL] [Abstract][Full Text] [Related]
12. Becker muscular dystrophy with widespread muscle hypertrophy and a non-sense mutation of exon 2.
Witting N; Duno M; Vissing J
Neuromuscul Disord; 2013 Jan; 23(1):25-8. PubMed ID: 22939275
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a complex Duchenne muscular dystrophy-causing dystrophin gene inversion and restoration of the reading frame by induced exon skipping.
Madden HR; Fletcher S; Davis MR; Wilton SD
Hum Mutat; 2009 Jan; 30(1):22-8. PubMed ID: 18570328
[TBL] [Abstract][Full Text] [Related]
14. Development of therapy for Duchenne muscular dystrophy.
Zhang S; Xie H; Zhou G; Yang Z
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Feb; 21(2):194-203. PubMed ID: 17357471
[TBL] [Abstract][Full Text] [Related]
15. Systemic human minidystrophin gene transfer improves functions and life span of dystrophin and dystrophin/utrophin-deficient mice.
Wang B; Li J; Fu FH; Xiao X
J Orthop Res; 2009 Apr; 27(4):421-6. PubMed ID: 18973234
[TBL] [Abstract][Full Text] [Related]
16. Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations.
Aartsma-Rus A; Fokkema I; Verschuuren J; Ginjaar I; van Deutekom J; van Ommen GJ; den Dunnen JT
Hum Mutat; 2009 Mar; 30(3):293-9. PubMed ID: 19156838
[TBL] [Abstract][Full Text] [Related]
17. [Don't stop me now!].
Wolf A; Schaack J; Freikamp L; Reutzel S; Zündorf I; Dingermann T
Pharm Unserer Zeit; 2008; 37(5):356-7. PubMed ID: 18729286
[No Abstract] [Full Text] [Related]
18. Advances in Duchenne muscular dystrophy gene therapy.
van Deutekom JC; van Ommen GJ
Nat Rev Genet; 2003 Oct; 4(10):774-83. PubMed ID: 14526374
[TBL] [Abstract][Full Text] [Related]
19. Paternal inheritance or a de novo mutation in a Duchenne Muscular Dystrophy pedigree from South India.
Purushottam M; Murthy AR; Shubha GN; Gayathri N; Nalini A
J Neurol Sci; 2008 May; 268(1-2):179-82. PubMed ID: 18031759
[TBL] [Abstract][Full Text] [Related]
20. Duchenne muscular dystrophy: stalled at the junction?
Ségalat L; Anderson JE
Eur J Hum Genet; 2005 Jan; 13(1):4-5. PubMed ID: 15483645
[No Abstract] [Full Text] [Related]
[Next] [New Search]
